SI2844647T1 - Postopek za pripavo optično čistih in po izbiri substituiranih derivatov 2-(1-hidroksi-alkil)-kromen-4-ona in njihova uporaba pri pripravi zdravil - Google Patents

Postopek za pripavo optično čistih in po izbiri substituiranih derivatov 2-(1-hidroksi-alkil)-kromen-4-ona in njihova uporaba pri pripravi zdravil

Info

Publication number
SI2844647T1
SI2844647T1 SI201331803T SI201331803T SI2844647T1 SI 2844647 T1 SI2844647 T1 SI 2844647T1 SI 201331803 T SI201331803 T SI 201331803T SI 201331803 T SI201331803 T SI 201331803T SI 2844647 T1 SI2844647 T1 SI 2844647T1
Authority
SI
Slovenia
Prior art keywords
chromen
hydroxy
derivatives
alkyl
preparation
Prior art date
Application number
SI201331803T
Other languages
English (en)
Inventor
Jayaraman Venkat Raman
Swaroop Kumar Venkata Satya Vakkalanka
Original Assignee
Rhizen Pharmaceuticals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54193684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2844647(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhizen Pharmaceuticals S.A. filed Critical Rhizen Pharmaceuticals S.A.
Publication of SI2844647T1 publication Critical patent/SI2844647T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
SI201331803T 2012-05-04 2013-05-03 Postopek za pripavo optično čistih in po izbiri substituiranih derivatov 2-(1-hidroksi-alkil)-kromen-4-ona in njihova uporaba pri pripravi zdravil SI2844647T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1737CH2012 2012-05-04
US201261671956P 2012-07-16 2012-07-16
PCT/IB2013/053544 WO2013164801A1 (en) 2012-05-04 2013-05-03 Process for preparation of optically pure and optionally substituted 2- (1 -hydroxy- alkyl) - chromen - 4 - one derivatives and their use in preparing pharmaceuticals
EP13729095.3A EP2844647B1 (en) 2012-05-04 2013-05-03 Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals

Publications (1)

Publication Number Publication Date
SI2844647T1 true SI2844647T1 (sl) 2020-12-31

Family

ID=54193684

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201331803T SI2844647T1 (sl) 2012-05-04 2013-05-03 Postopek za pripavo optično čistih in po izbiri substituiranih derivatov 2-(1-hidroksi-alkil)-kromen-4-ona in njihova uporaba pri pripravi zdravil

Country Status (25)

Country Link
US (1) US9309216B2 (sl)
EP (1) EP2844647B1 (sl)
JP (2) JP6290186B2 (sl)
KR (1) KR102073181B1 (sl)
CN (2) CN108084138A (sl)
AP (1) AP3547A (sl)
AU (1) AU2013255469B2 (sl)
BR (1) BR112014027470A2 (sl)
CA (1) CA2871000C (sl)
CL (1) CL2014002986A1 (sl)
CO (1) CO7141413A2 (sl)
CY (1) CY1123456T1 (sl)
EA (1) EA032812B1 (sl)
HK (1) HK1203964A1 (sl)
IL (1) IL235181A (sl)
MX (1) MX365250B (sl)
MY (1) MY171207A (sl)
NZ (1) NZ701198A (sl)
PH (1) PH12014502453B1 (sl)
PL (1) PL2844647T3 (sl)
RS (1) RS61035B1 (sl)
SG (1) SG11201407184PA (sl)
SI (1) SI2844647T1 (sl)
WO (1) WO2013164801A1 (sl)
ZA (1) ZA201407769B (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010316780B2 (en) 2009-11-05 2015-07-16 Rhizen Pharmaceuticals Sa Novel benzopyran kinase modulators
SI2844647T1 (sl) * 2012-05-04 2020-12-31 Rhizen Pharmaceuticals S.A. Postopek za pripavo optično čistih in po izbiri substituiranih derivatov 2-(1-hidroksi-alkil)-kromen-4-ona in njihova uporaba pri pripravi zdravil
US10130635B2 (en) * 2012-05-04 2018-11-20 Rhizen Pharmaceuticals Sa Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals
SI3004106T1 (sl) 2013-06-07 2018-03-30 Rhizen Pharmaceuticals S.A. Dvojni selektivni inhibitorji PI3 delta in gama
ES2708748T3 (es) 2014-06-27 2019-04-11 Rhizen Pharmaceuticals S A Derivados de cromeno sustituidos como inhibidores duales selectivos de proteína cinasas PI3 delta y gamma
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EP3325462A4 (en) * 2015-07-23 2019-06-19 Pharmakea, Inc. INHIBITORS OF LYSYL OXIDASE-LIKE 2 AND USES OF SAID INHIBITORS
EP3414229B1 (en) 2016-02-09 2021-06-16 Pharmakea, Inc. Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2023130334A1 (zh) * 2022-01-07 2023-07-13 同润生物医药(上海)有限公司 一种色烯-4-酮化合物及其中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62201882A (ja) * 1985-11-18 1987-09-05 Yamanouchi Pharmaceut Co Ltd イソフラボン誘導体
PE20060426A1 (es) * 2004-06-02 2006-06-28 Schering Corp DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa
AU2010316780B2 (en) 2009-11-05 2015-07-16 Rhizen Pharmaceuticals Sa Novel benzopyran kinase modulators
ES2710874T3 (es) * 2011-05-04 2019-04-29 Rhizen Pharmaceuticals S A Compuestos novedosos como moduladores de proteína cinasas
SI2844647T1 (sl) * 2012-05-04 2020-12-31 Rhizen Pharmaceuticals S.A. Postopek za pripavo optično čistih in po izbiri substituiranih derivatov 2-(1-hidroksi-alkil)-kromen-4-ona in njihova uporaba pri pripravi zdravil
CN104470923B (zh) * 2012-07-04 2019-03-29 理森制药股份公司 选择性PI3K δ抑制剂

Also Published As

Publication number Publication date
AP2014008087A0 (en) 2014-11-30
CL2014002986A1 (es) 2015-01-09
PH12014502453A1 (en) 2015-03-16
RS61035B1 (sr) 2020-12-31
CN108084138A (zh) 2018-05-29
EA201491818A1 (ru) 2015-04-30
CO7141413A2 (es) 2014-12-12
PL2844647T3 (pl) 2021-01-25
CA2871000C (en) 2021-10-19
EA032812B1 (ru) 2019-07-31
CY1123456T1 (el) 2022-03-24
IL235181A (en) 2017-12-31
MX2014013426A (es) 2015-05-11
ZA201407769B (en) 2016-05-25
KR20150006876A (ko) 2015-01-19
JP6290186B2 (ja) 2018-03-07
NZ701198A (en) 2016-09-30
US9309216B2 (en) 2016-04-12
CN104507922B (zh) 2018-02-09
EP2844647B1 (en) 2020-07-22
EP2844647A1 (en) 2015-03-11
WO2013164801A1 (en) 2013-11-07
JP2015515975A (ja) 2015-06-04
HK1203964A1 (en) 2015-11-06
CN104507922A (zh) 2015-04-08
AU2013255469A1 (en) 2014-11-13
AU2013255469B2 (en) 2017-10-12
PH12014502453B1 (en) 2015-03-16
US20150087699A1 (en) 2015-03-26
SG11201407184PA (en) 2014-12-30
KR102073181B1 (ko) 2020-02-04
MY171207A (en) 2019-10-02
JP2018039849A (ja) 2018-03-15
BR112014027470A2 (pt) 2017-06-27
MX365250B (es) 2019-05-28
AP3547A (en) 2016-01-14
CA2871000A1 (en) 2013-11-07

Similar Documents

Publication Publication Date Title
HK1203964A1 (en) Process for preparation of optically pure and optionally substituted 2- (1 -hydroxy- alkyl) - chromen - 4 - one derivatives and their use in preparing pharmaceuticals 2-(1--)--4-
HK1198476A1 (zh) 咪唑啉類衍生物、其製備方法及其在醫藥上的應用
EP2834224A4 (en) PROCESSES FOR THE PREPARATION OF BENZIMIDAZOLE DERIVATIVES AND SALTS THEREOF
HK1187335A1 (en) Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals 3--
IL227711A0 (en) Phenyl-isoxazole history and their preparation process
PL2726486T3 (pl) Nowe estry n-acylowanych pochodnych aminokwasów i izosorbidu, sposób ich wytwarzania i ich zastosowanie w kosmetyku i jako leku
EP2865666A4 (en) HEXAHYDROPENTALENE DERIVATIVES, METHOD OF MANUFACTURE AND USE IN MEDICINE
GB201218084D0 (en) Novel compounds and methods for use in medicine
ZA201407214B (en) Therapeutic preparation and process for preparing said therapeutic preparation
PL399613A1 (pl) Pochodne estrów diarylowych kwasów 1-aminoalkanofosfonowych, sposób wytwarzania pochodnych estrów diarylowych kwasów 1-aminoalkanofosfonowych oraz ich zastosowanie
HRP20160687T1 (hr) Supstituirani 2-(kroman-6-iloksi)tiazoli i njihova upotreba kao farmaceutska sredstva
PT2844647T (pt) Processo para preparação de derivados de 2-(1-hidroxialquil)- cromen-4-ona oticamente puros e opcionalmente substituídos e utilização dos mesmos na preparação de produtos farmacêuticos
IL238934A0 (en) Methods for the preparation of phenyloxymethyl-nitro-imidazole derivatives and their use
IL231096A0 (en) 2-converted thiazoles (chroman-6-yloxy) and their use as pharmaceutical preparations
IL212725A (en) Glycerol Preparation for Non-surgical Conjunctivochalysis
PL398945A1 (pl) Chiralne symetryczne sole imidazoliowe, pochodne alkoholu nasyconego oraz sposób ich wytwarzania
PL398940A1 (pl) Optycznie czynne symetryczne sole imidazolowe pochodne monoterpenowego alkoholu oraz sposób ich wytwarzania